SEC Form 4 · accession 0000019446-15-000014
CANTEL MEDICAL CORP · CMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles M Diker
Officer — Chairman · Director · 10% Owner
Period of report
Mar 19, 2015
Accepted (ET)
Mar 20, 2015 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.10 per shareF1 | Mar 19, 2015 | S | 3,000 | $46.5328 | D | 3,282,487 | D | |
| Common Stock, par value $.10 per shareF2 | Mar 20, 2015 | S | 6,000 | $46.73 | D | 3,276,487 | D | |
| Common Stock, par value $.10 per share | holding | — | — | — | 477,488 | I | By wife | |
| Common Stock, par value $.10 per share | holding | — | — | — | 82,294 | I | By custodial accounts for benefit of grandchildren | |
| Common Stock, par value $.10 per share | holding | — | — | — | 234,271 | I | By trust for benefit of children | |
| Common Stock, par value $.10 per share | holding | — | — | — | 29,430 | I | Shares held by Dico Group, Inc. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The per share sale prices ranged from $45.37 to $46.69. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price.
- F2The per share sale prices ranged from $46.595 to $47.64. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price.